noscript

News and Announcements

Bioactive Laboratories Closing their Fundraising Round Early

  • Published August 06, 2014 5:02PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Bioactive Laboratories, a developer of a world first anti-inflammatory & pain relieving agent that is gentle to the stomach, closes their current fund raising campaign early.

Rick Ferdinands MD describes this fund raising experience: “Bioactive are grateful to the Wholesale Investor team; it’s the most effective platform to meet qualified investors in Australia. We are now able to close this fund raising campaign early and get on with business”.

As there are a number of investors who weren’t aware of the closure, Bioactive Laboratories have extended the deadline to Friday, 22nd August 2014.

As you can imagine with the strong response to the campaign, the company have already commenced the next stages of their strategic plan featuring the TGA registration completion, production trials and further customer engagement.

For those who could not make it to the Melbourne Showcase in July, you can view Rick’s presentation at www.bioactivelab.com.au/news/

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now